Some important issues in the planning of phase III HIV vaccine efficacy trials

Vaccine ◽  
1999 ◽  
Vol 17 (7-8) ◽  
pp. 989-1004 ◽  
Author(s):  
M.-C. Boily ◽  
B.R. Mâsse ◽  
K. Desai ◽  
M. Alary ◽  
R.M. Anderson
Keyword(s):  
Vaccine Efficacy ◽  
Hiv Vaccine ◽  
Phase Iii ◽  
Efficacy Trials

Preparation for Phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence

AIDS ◽  
1994 ◽  
Vol 8 (9) ◽  
pp. 1285-1291 ◽  
Author(s):  
William L. Heyward ◽  
Saladin Osmanov ◽  
Joseph Saba ◽  
Jose Esparza ◽  
Elizabeth Belsey ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Hiv Vaccine ◽  
Phase Iii ◽  
Hiv Incidence ◽  
Efficacy Trials

scholarly journals Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda

Vaccine ◽  
2013 ◽  
Vol 31 (44) ◽  
pp. 5055-5061 ◽  
Author(s):  
Gershim Asiki ◽  
Andrew Abaasa ◽  
Eugene Ruzagira ◽  
Freddie Kibengo ◽  
Ubaldo Bahemuka ◽  
...  
Keyword(s):  
High Risk ◽  
Vaccine Efficacy ◽  
Lake Victoria ◽  
Hiv Vaccine ◽  
Fishing Communities ◽  
Willingness To Participate ◽  
Men And Women ◽  
Efficacy Trials

scholarly journals Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda

Retrovirology ◽  
2012 ◽  
Vol 9 (S2) ◽  
Author(s):  
A Nanvubya ◽  
J Mpendo ◽  
A Ssetaala ◽  
W Kidega ◽  
S Sigirenda ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Hiv Vaccine ◽  
Fishing Communities ◽  
Willingness To Participate ◽  
Efficacy Trials

Identification of a High-Risk Heterosexual Cohort for HIV Vaccine Efficacy Trials in Rio de Janeiro, Brazil, Using a Sensitive/Less-Sensitive Assay: An Update

2004 ◽  
Vol 36 (3) ◽  
pp. 880-881 ◽  
Author(s):  
Paulo Feijó Barroso ◽  
Lee H. Harrison ◽  
Maria de Fátima Melo ◽  
Sônia Maria Batista ◽  
Marilene da Silva Bastos ◽  
...  
Keyword(s):  
High Risk ◽  
Vaccine Efficacy ◽  
Rio De Janeiro ◽  
Hiv Vaccine ◽  
Sensitive Assay ◽  
Efficacy Trials

scholarly journals Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa

PLoS ONE ◽  
2016 ◽  
Vol 11 (7) ◽  
pp. e0157391 ◽  
Author(s):  
Carlo Zambonelli ◽  
Antu K. Dey ◽  
Susan Hilt ◽  
Samuel Stephenson ◽  
Eden P. Go ◽  
...  
Keyword(s):  
Southern Africa ◽  
Vaccine Efficacy ◽  
Hiv Vaccine ◽  
Proof Of Concept ◽  
Subtype C ◽  
Efficacy Trials ◽  
Gp120 Protein ◽  
Protein Boost ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document